Cook CE marks Zilver PTX
This article was originally published in Clinica
Executive Summary
Cook Medical has CE marked its Zilver PTX paclitaxel-eluting stent for sale in Europe. The polymer-free device is designed for use in peripheral artery disease (PAD); specifically, to treat severe blockages in the superficial femoral artery. The self-expanding stent, made of Nitinol, was implanted in patients for the first time on August 10. PAD is estimated to affect 27 million individuals in Europe and North America, three quarters of whom are asymptomatic. The stent is not yet approved for sale in the US.